ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

SOCMA Asks Congress for Carcinogen Classification Probe

March 25, 1988

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

In Brief: Des Exposed Women Face New Risk: Unfavorable Pregnancies; Hutchinson Labor Election Set

March 21, 1980

NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board”

March 11, 1983